|
FBXL14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.840970E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.944800E-03 |
| Normal-vs-Stage2 |
3.181000E-01 |
| Normal-vs-Stage3 |
6.022300E-04 |
| Normal-vs-Stage4 |
2.315600E-03 |
| Stage1-vs-Stage2 |
1.918040E-01 |
| Stage1-vs-Stage3 |
9.854000E-02 |
| Stage1-vs-Stage4 |
2.438200E-01 |
| Stage2-vs-Stage3 |
2.933900E-02 |
| Stage2-vs-Stage4 |
5.402200E-02 |
| Stage3-vs-Stage4 |
9.133200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.207900E-04 |
| Normal-vs-AfricanAmerican |
1.500450E-01 |
| Normal-vs-Asian |
2.916200E-01 |
| Caucasian-vs-AfricanAmerican |
3.809200E-01 |
| Caucasian-vs-Asian |
4.304200E-02 |
| AfricanAmerican-vs-Asian |
5.760800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.515500E-03 |
| Normal-vs-Female |
3.501800E-03 |
| Male-vs-Female |
4.146400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.679500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.555970E-02 |
| Normal-vs-Age(61-80Yrs) |
1.075480E-03 |
| Normal-vs-Age(81-100Yrs) |
3.725600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.800600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.191000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.255600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.049000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.177400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.230000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.155880E-04 |
| Classical-VS-Follicular |
3.131200E-01 |
| Classical-VS-Other |
3.062600E-01 |
| Classical-VS-Normal |
2.440400E-02 |
| Tall-VS-Follicular |
9.184500E-03 |
| Tall-VS-Other |
5.788600E-01 |
| Tall-VS-Normal |
1.53559999999109E-05 |
| Follicular-VS-Other |
4.993600E-01 |
| Follicular-VS-Normal |
1.005770E-02 |
| Other-VS-Normal |
8.526200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.279740E-02 |
| Normal-vs-N1 |
5.50059999999686E-05 |
| N0-vs-N1 |
1.323510E-02 |
|
|
